Volume 28, Number 1—January 2022
Research
Transmission Dynamics of Large Coronavirus Disease Outbreak in Homeless Shelter, Chicago, Illinois, USA, 2020
Table 3
Parameter | Fitted value | Description of parameter |
---|---|---|
β0 | 0.60 | Initial β |
βf_pct_β0 | 0.11 | Final β as percentage of β0 |
k | 2.0 | Rate of transformation of β |
tTrans | 23 | Day where β reaches halfway between β0 and βf |
σs | 0.098 | Rate of transition from E to Is compartment = 1/(incubation period) × (% symptomatic) |
σa | 0.26 | Rate of transition from E to Ia compartment = 1/(incubation period) × (% asymptomatic) |
Asymptomatic percentage | 0.73 | Asymptomatic percentage |
ϒsp | 0.15 | Rate of transition from Is to Rs+ compartment = 1/(infectious period for symptomatic persons) |
ϒap | 0.13 | Rate of transition from Ia to Ra+ compartment = 1/(infectious period for asymptomatic persons) |
ϒsn | 0.046 | Rate of transition from Rs+ to R- compartment = 1/[(duration of RT-PCR–positivity) – (infectious period)] for symptomatic persons |
ϒan | 0.12 | Rate of transition from Ra+ to R- compartment = 1/[(duration of RT-PCR–positivity) – (infectious period]) for asymptomatic persons |
α | 0.32 | Rate of detection of I symptomatic persons through screening |
λ0_pct_β | 1 | Rate of transmission between persons in Isolsoft and Susceptible compartment, as a percentage of β |
λisol_pct_β | 1 | Rate of transmission between persons in isolation units and Susceptible compartment, as a percentage of β |
ρ | 1/14 d* | Rate of return from isolation units to Recovered compartment = 1/[14 d]† |
PCR sensitivity | 0.90 | RT-PCR sensitivity |
ω0 | 0.75 | Rate of hospital admission of Infectious symptomatic persons before screening |
ω | 0.39 | Rate of hospital admission of Isolsoft symptomatic persons during phase 2 |
*Details of optimization and calculation can be found in the Appendix. E, exposed; I, infectious; RT-PCR, reverse transcription PCR. †Value not fitted.
1These senior authors contributed equally to this article.
Page created: October 08, 2021
Page updated: December 20, 2021
Page reviewed: December 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.